Anti-inflammatory and Immunomodulatory Compounds from Marine Algae
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (20 December 2021) | Viewed by 11958
Interests: drug discovery; bioassay development; algal toxins and natural products; immunology; inflammation modulation
Special Issues, Collections and Topics in MDPI journals
Chronic and unresolved inflammation has been implicated as a factor or co-factor in a myriad of disease states. As current treatment options are often unsatisfactory for resolving inflammation, new therapeutics are needed to help combat the life-threatening complications due to chronic inflammation. Marine algae have been shown to be a veritable source of novel compounds with anti-inflammatory action. Algae are rich in polyunsaturated fatty acids, precursors to many inflammation resolving compounds. Marine algae also contain a myriad of other structurally diverse compounds with potential anti-inflammatory bioactivity.
This Special Issue will house a collection of research articles and reviews on anti-inflammatory and immunomodulatory bioactivity from marine algae. In particular, we are interested in the discovery of new compounds with anti-inflammatory actions, and also newly described anti-inflammatory or immunomodulatory bioactivity of previously described marine natural products.
Dr. Jennifer McCall
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- marine compounds